Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
64,945,642
-
Share change
-
+4,266,245
-
Total reported value
-
$586,470,031
-
Put/Call ratio
-
84%
-
Price per share
-
$9.03
-
Number of holders
-
96
-
Value change
-
+$36,664,370
-
Number of buys
-
56
-
Number of sells
-
40
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q1 2015
As of 31 Mar 2015,
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,945,642 shares.
The largest 10 holders included
FMR LLC, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BlackRock Fund Advisors, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, RTW INVESTMENTS, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
96
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.